Retina Associates of Cleveland, Inc.

Cleveland, Ohio 44126

2 studies enrolling now · 9 studies all time

What they study most

Central Retinal Vein Occlusion, Diabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, MacTel (Macular Telangiectasia) Type 2, Macular Edema, Diabetic, Macular Telangiectasia Type 2 (MacTel)

Studies at this site

• Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) — Completed
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A — Completed
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema — Completed
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema — Stopped early